Standex International Corporation reported its financial results for the fourth quarter and full fiscal year 2025, which ended June 30, 2025. For Q4 FY25, net sales increased by 23.2% year-on-year to $222.0 million, with adjusted operating margin expanding 350 basis points year-on-year to a record 20.6%. Adjusted earnings per share grew over 20% to a record $2.28.
For the full fiscal year 2025, consolidated net sales increased by 9.6% to $790.11 million, driven by acquisitions contributing 17.2% to sales. The company achieved a record adjusted operating margin of 19.1% and record adjusted earnings per share of $7.98, up 5.8% year-on-year. Standex also paid down approximately $27 million of debt in Q4 FY25, reducing its net leverage ratio to 2.6x.
Fast-growth market sales totaled $61 million in Q4 FY25, exceeding expectations for the fiscal year, and 16 new products were launched in FY25, delivering 2.5% of incremental sales. Capacity for Amran/Narayan was expanded in Houston and India, with a new greenfield site in Croatia commissioning for shipments within four months.
For fiscal year 2026, Standex expects revenue to grow by over $100 million and anticipates continued adjusted operating margin expansion. This growth is projected to be driven by mid-to-high-single-digit organic growth in Electronics, double-digit organic growth in Engineering Technologies, and the full contribution from recent acquisitions.
The company plans to release over fifteen new products in FY26, contributing approximately 300 basis points of incremental growth. Sales from fast-growth markets are expected to grow approximately 45% year-on-year, exceeding $265 million. Standex remains on track to achieve its fiscal 2028 targets of sales greater than $1.15 billion and adjusted operating margin greater than 23%.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.